XML 22 R12.htm IDEA: XBRL DOCUMENT v3.25.3
STOCK BASED AWARDS
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
STOCK BASED AWARDS

NOTE 6. STOCK BASED AWARDS

 

Stock-based compensation expense of $134 and $127 for the three months ended September 30, 2025 and 2024, respectively, and $369 and $334 for the nine months ended September 30, 2025 and 2024, respectively, was reported in the condensed consolidated statements of operations within general and administrative expenses.

 

Stock Options

 

Under the 2017 Stock Incentive Plan (“2017 Plan”), as amended, there are an aggregate of 775,000 shares authorized for issuance.

 

 

We granted no and 43,382 service-based stock options during the three and nine months ended September 30, 2025. We granted 1,000 and 23,000 service-based stock options during the three and nine months ended September 30, 2024, respectively. Weighted average stock option fair value assumptions and the weighted average grant date fair value of stock options granted were as follows:

 

  

   2025   2024 
Stock option fair value assumptions:          
Risk-free interest rate   4.14%   4.38%
Expected life (years)   6.4    6.0 
Dividend yield   -%   -%
Expected volatility   58%   58%
Weighted average grant date fair value of stock options granted  $5.21   $6.49 

 

Total compensation expense related to stock options was $84 and $206 for the three and nine months ended September 30, 2025, respectively. Total compensation expense related to stock options was $61 and $184 for the three and nine months ended September 30, 2024, respectively. As of September 30, 2025, there was $680 of unrecognized compensation related to stock options which will be recognized over a weighted average period of 2.4 years.

 

Following is a summary of stock option activity as of and for the nine months ended September 30, 2025 and 2024:

 

  

   Shares  

Weighted-

Average

Exercise Price

Per Share

  

Weighted-

Average

Remaining

Contractual

Term

(in years)

  

Aggregate

Intrinsic Value

 
Outstanding – December 31, 2023   458,700   $6.63    6.53   $1,432 
Granted   23,000    11.08           
Exercised   (5,500)   5.42           
Forfeited   (12,400)   10.13           
Outstanding – September 30, 2024   463,800   $6.78    5.94   $2,301 
                     
Outstanding – December 31, 2024   453,400   $6.79    5.70   $1,654 
Granted   43,382    8.73           
Exercised   (1,200)   3.98           
Forfeited   (10,400)   8.22           
Outstanding – September 30, 2025   485,182   $6.91    5.34   $1,244 
Exercisable on September 30, 2025   310,200   $5.36    3.9   $1,223 

 

Restricted Stock Units

 

Total compensation expense related to restricted stock units (“RSUs”) was $50 and $163 for the three and nine months ended September 30, 2025, respectively. Total compensation expense related to RSUs was $66 and $150 for the three and nine months ended September 30, 2024, respectively. During the nine-month periods ended September 30, 2025 and 2024, we granted 43,664 and 15,141 RSUs, respectively, at an average grant price per share of $8.73 and $11.06, respectively, under our 2017 Stock Incentive Plan to non-employee directors which vest over two years. As of September 30, 2025, total unrecognized compensation expense related to the RSUs was $306, which will vest over a weighted average period of 1.6 years.

 

 

Following is a summary of RSU activity as of and for the nine months ended September 30, 2025 and 2024:

 

  

   Shares  

Weighted-

Average

Remaining

Vesting

Term

(in years)

  

Aggregate

Intrinsic Value

 
Outstanding – December 31, 2023   27,000    1.0   $254 
Granted   15,141           
Vested   (16,500)          
Forfeited   (1,500)          
Outstanding – September 30, 2024   24,141    0.6   $283 
                
Outstanding – December 31, 2024   24,141    0.3   $248 
Granted   43,664           
Vested   (24,141)          
Forfeited   -           
Outstanding – September 30, 2025   43,664    1.6   $394